WHO welcomes report on efficacy of longer gaps between AstraZeneca doses

FILE PHOTO: A logo is pictured outside a building of the World Health Organization (WHO) during an executive board meeting on update on the coronavirus disease (COVID-19) outbreak, in Geneva, Switzerland, April 6, 2021. REUTERS/Denis Balibouse

GENEVA (Reuters) – A report from Oxford University saying that a longer gap between doses of AstraZeneca vaccines still provides protection is “very reassuring” for supply-strapped countries, World Health Organization chief scientist Soumya Swaminathan said on Friday.

Joachim Hombach, head of the WHO’s expert panel, said it was “great news” on spaced dosing for the vaccine, which would add flexibility to dosing schedules.

The Oxford study released this week found that the second dose can be delayed up to 45 weeks and still lead to an enhanced immune response.

Source: Read Full Article

Related posts:
  1. Mexico reports 7,030 new coronavirus cases, 462 more deaths
  2. Slovakia seeks medical staff assist from abroad as COVID-19 outbreak rages
  3. AstraZeneca vaccine faces resistance in Europe after health workers suffer side-effects
  4. Denmark suspends AstraZeneca COVID shots for two weeks after blood clot reports
  5. Heart inflammation cases in young men higher than expected after mRNA vaccines: U.S. CDC